↓ Skip to main content

Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Average Attention Score compared to outputs of the same age and source

Citations

dimensions_citation
101 Dimensions

Readers on

mendeley
141 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd008107.pub2
Pubmed ID
Authors

Ulrich Ronellenfitsch, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Meinhard Kieser, Tracy E Slanger, Katrin Jensen

Abstract

The outcome of patients with locally advanced gastroesophageal adenocarcinoma (adenocarcinoma of the esophagus, gastroesophageal (GE) junction, and stomach) is poor. There is conflicting evidence regarding the effects of perioperative chemotherapy on survival and other outcomes.

Mendeley readers

The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Unknown 140 99%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 18 13%
Student > Master 18 13%
Student > Ph. D. Student 17 12%
Researcher 16 11%
Student > Bachelor 15 11%
Other 41 29%
Unknown 16 11%
Readers by discipline Count As %
Medicine and Dentistry 98 70%
Nursing and Health Professions 7 5%
Biochemistry, Genetics and Molecular Biology 2 1%
Pharmacology, Toxicology and Pharmaceutical Science 2 1%
Psychology 2 1%
Other 5 4%
Unknown 25 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 October 2018.
All research outputs
#3,570,938
of 13,622,595 outputs
Outputs from Cochrane database of systematic reviews
#6,403
of 10,684 outputs
Outputs of similar age
#39,113
of 158,299 outputs
Outputs of similar age from Cochrane database of systematic reviews
#61
of 123 outputs
Altmetric has tracked 13,622,595 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 10,684 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,299 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.